Pure red cell aplasia in a patient of chronic granulocyte leukemia associated with imatinib.
Meng
Hai-tao
HT
Li
Ying
Y
Jin
Jie
J
Qian
Wen-bin
WB
Yang
Chun-mei
CM
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001549:Benzamides; D001772:Blood Cell Count; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000473:pathology; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D012010:Red-Cell Aplasia, Pure / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate